Results 151 to 160 of about 704 (162)
Some of the next articles are maybe not open access.

Cumulative dose of bevacizumab associates with albuminuria rather than podocyturia in cancer patients

Journal of the American Society of Hypertension, 2018
Angiogenesis inhibition with bevacizumab, a monoclonal antibody against vascular endothelial growth factor A (VEGF-A), is an anticancer treatment associated with hypertension and renal glomerular toxicity referred to as a preeclampsia-like syndrome. In preeclampsia, podocyturia predates proteinuria and clinical features of preeclampsia, and is regarded
Lankhorst, Stephanie   +7 more
openaire   +2 more sources

Viable Podocyturia in Healthy Individuals: Implications for Podocytopathies

American Journal of Kidney Diseases, 2014
Silvia, Maestroni   +8 more
openaire   +2 more sources

EFFECTS OF SGLT2 INHIBITORS ON DIABETIC NEPHROPATHY: PODOCYTURIA ON FOCUS

2020
[No abstract available]
Özkan, Serbay   +6 more
openaire   +1 more source

342 Podocyturia As An Early Marker of Preeclampsia

American Journal of Kidney Diseases, 2011
Steven Wagner   +3 more
openaire   +1 more source

Podocyturia is a sensitive and specific marker for preeclampsia

American Journal of Obstetrics and Gynecology, 2006
David Rosenthal   +6 more
openaire   +1 more source

Podocyturia is a marker of preeclampsia

Nature Clinical Practice Nephrology, 2007
openaire   +1 more source

P46 Podocyturia may reflect ongoing glomerular disturbance in preeclampsia

Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, 2010
Nelson Sass   +6 more
openaire   +1 more source

Podocyturia in Fabry disease: a tool for monitoring renal disorders

Molecular Genetics and Metabolism, 2014
Ester M. Pereira   +4 more
openaire   +1 more source

Pre-eclampsia, podocyturia and the role of parietal epithelial cells

Nature Reviews Nephrology, 2014
Turgay Saritas, Marcus J. Moeller
openaire   +1 more source

Home - About - Disclaimer - Privacy